Lim Tse Mun

Title: Lim Tse Mun: Innovator in COX-2 Inhibition

Introduction

Lim Tse Mun is a notable inventor based in Kuala Lumpur, Malaysia. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific enzymes involved in inflammatory processes.

Latest Patents

Lim Tse Mun holds a patent for "Thieno[2,3-d]pyrimidines as COX-2 inhibitors." This patent outlines methods for inhibiting the cyclooxygenase enzyme-2 (COX-2) using thieno[2,3-d]pyrimidine compounds. These methods can be effective for treating inflammation, pain, or any other COX-2 mediated disorder. He has 1 patent to his name.

Career Highlights

Lim Tse Mun is affiliated with King Fahd University of Petroleum and Minerals, where he engages in research and development activities. His work focuses on innovative solutions to complex medical challenges, particularly those related to pain and inflammation.

Collaborations

Some of his notable coworkers include Katharigatta N Venugopala and Pran Kishore Deb. Their collaborative efforts contribute to advancing research in their respective fields.

Conclusion

Lim Tse Mun's work in developing COX-2 inhibitors showcases his commitment to addressing significant health issues through innovative research. His contributions are valuable in the ongoing quest for effective treatments for inflammatory disorders.